AI & Robotics

In the data science community, we’re witnessing the beginnings of an infodemic — where more data becomes a liability rather than an asset. We’re continuously moving towards ever more data-hungry and more computationally expensive state-of-the-art AI models. And that is going to result in some detrimental and perhaps counter-intuitive side-effects (I’ll get to those shortly). To avoid…

Since the start of the pandemic, there’s been an influx of papers on epidemic forecasting. Indeed, as of February, a search for “COVID forecasting” on Google Scholar yields over 14,000 results. But while many researchers compare their approaches against traditional modeling strategies, forecasts are highly sensitive to the implementation, which requires a well-defined benchmark. Researchers…

Immunai, a startup developing an AI platform to analyze the human immune system, today announced that it raised $60 million. The company says it will use the funds to broaden its functional genomics capabilities and help its partners prioritize, discover, and develop new therapies and drug combinations. Emerging treatments like gene cell therapies and cancer immunotherapies promise to…

The soaring number of cyberattacks in recent years has propelled a massive expansion of potential solutions as startups and incumbent security providers jostle to address the market opportunity. But Tel Aviv-based CYE believes it has developed a way to cut through that clutter with a solution that uses artificial intelligence to probe for technical weaknesses and human hackers to test a…